Wednesday, May 1, 2019

New CPIC Guideline: CYP2B6 and efavirenz

›
The CPIC Guideline for CYP2B6 and efavirenz is now published in  Clinical Pharmacology and Therapeutics . The accepted article can be view...
Wednesday, April 17, 2019

PharmGKB opinion piece on pharmacogenomic RCTs published in Clinical Pharmacology and Therapeutics

›
Is supporting evidence from a randomized controlled trial (RCT) always necessary when implementing pharmacogenomics in the clinic? In an op...
Monday, April 15, 2019

CYP2C19 testing may assist with prescribing sertraline and escitalopram

›
Mary Relling (St. Jude Children's Research Hospital) and I (Teri Klein) as Co-Principal Investigators of the Clinical Pharmacogenetics I...
1 comment:
Tuesday, March 5, 2019

New CPIC Guideline: CYP2D6 and atomoxetine

›
The CPIC Guideline for atomoxetine and CYP2D6 is now published in Clinical Pharmacology and Therapeutics . The accepted article can be view...
Tuesday, December 11, 2018

New CPIC guideline: potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes

›
The CPIC Guidelines for  potent volatile anesthetic agents and succinylcholine in the context of   RYR1   or   CACNA1S   genotypes  is now ...
Friday, December 7, 2018

CPIC Dosing Guidelines for DPYD and Fluoropyrimidines Updated

›
An update to the CPIC dosing guidelines for DPYD and fluoropyrimidines has recently been added to the CPIC and PharmGKB websites. The mo...
Tuesday, December 4, 2018

New biogeographical groups in use at PharmGKB

›
Recent visitors to the PharmGKB website may have noticed a change in how we report racial and ethnicity information in our v...